Idris Mohammed Idris, Diyae Nesredin Hassan, Hanan Abdelkadir Hassen, Rahwa Zerabruk Araya, Dawit G Weldemariam
Consumers' Perception of Generic Medicines and Evaluation of In Vitro Quality Control Parameters of Locally Manufactured Paracetamol Tablets in Asmara, Eritrea: A Cross-Sectional Study
BioMed research international
primary immunodeficiency diseases pidds rare yet lifethreatening chronic conditions children prevalence outcomes pidds pediatric population united states well understood objectives study 1 determine epidemiology children hospitalized pidd united states 2 characterize clinical outcomes hospitalized children pidds retrospective cohort analysis 20032012 kids inpatient database children aged 218 years admitted primary secondary diagnosis code pidd performed secondary immunodeficiency diseases excluded 26794 pediatric patients hospitalized diagnosis pidd 2003 2012 national prevalence pidds per 100000 666 822 974 1268 2003 2006 2009 2012 respectively highest prevalence children 05 years age 15105 hospitalizations 56 difference prevalence bcell defects tcell defects pidds affected ethnic populations equally respiratoryrelated diagnoses common comorbidity organ system overall mortality 199 age inversely correlated clinical outcome children 05 years higher mortality 424 deaths 7985 mean hospital charges 35480 length stay los 56 days compared older age cohorts prevalence pidds hospitalized pediatric population united states may increased time younger age associated higher mortality hospital costs los study needed determine costeffective management strategies improve outcomes infants young children pidd